Comparison of plasma and oral gargle HPV DNA clearance impacts progression-free survival in cancer patients, indicating potential prognostic value.
Supplemental Figure 3: Week 4 Plasma Cell-Free HPV (cfHPV) or Oral Gargle HPV DNA and its Association with Progression-free Survival (PFS). A) Comparison of PFS for patients with versus without week 4 plasma cfHPV DNA clearance. B) Comparison of PFS for patients with versus without week 4 oral gargle cfHPV DNA clearance. Log-rank test represents a comparison between the respective groups.
No takes yet. Share an insight, caveat, or question.
Echevarria et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: